Randomized Clinical Trial for Comparison Of Intravenous Carbeitocin Versus Oxytocin In Management Of Placental Delivery In Second Trimester Interruption
Phase 4
- Conditions
- CARBETOCIN FOR PREVENTION OF PLACENTAL RETAINED
- Interventions
- Registration Number
- NCT01827124
- Lead Sponsor
- Wafaa Uthman Ahmed
- Brief Summary
Intravenous Carbetocin is more efficient than intravenous infusion oxytocin in management of placental delivery in 2nd trimester interruption.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 140
Inclusion Criteria
- Age:16-50 years
- Pregnancy duration: 14-24weeks
- Spontaneous abortion or medical induced abortion at 14-24weeks
Exclusion Criteria
- Age less than 16years and more than 50 years
- Surgical termination
- Placenta previa
- Uterine fibroid
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description carbetocin and placebo oxytocin 100microgram carbetocin IV and 1cc normal saline(placebo)infusion carbetocin and placebo Carbetocin 100microgram carbetocin IV and 1cc normal saline(placebo)infusion oxytocin and placebo Carbetocin 20Interntional unit oxytocin infusion and 1cc normal saline IV oxytocin and placebo oxytocin 20Interntional unit oxytocin infusion and 1cc normal saline IV
- Primary Outcome Measures
Name Time Method Record duration of spontaneous placental expulsion after delivery of fetus in second trimester interruption at the time of delivery
- Secondary Outcome Measures
Name Time Method Estimation of blood loss in each group by weighing all pads put under the patient after delivery of fetus tell expulsion of placenta( before and after using of pads). at time of delivery
Trial Locations
- Locations (1)
Ain Shams university maternity hospital department of obstetrics and gynacology
🇪🇬Cairo, Tertiary, Egypt